Clinical trial
HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of…
NCT00147784 · Sorlandet Hospital HF, Other · Completed
Key facts
| NCT number | NCT00147784 |
|---|---|
| Title | HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. |
| Official title | HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group. |
| Lead sponsor | Sorlandet Hospital HF, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opiate Dependence, Hepatitis |
| Intervention type | Drug |
| Interventions | Ribavirin, Pegylated Interferon |
| Enrollment | 10 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Sep 7, 2005 |
| Last update posted | Mar 28, 2008 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: